• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同聚合物浓度对漂浮微球物理化学性质的影响。

Effect of various polymers concentrations on physicochemical properties of floating microspheres.

作者信息

Jagtap Y M, Bhujbal R K, Ranade A N, Ranpise N S

机构信息

Department of Pharmaceutics, STES's Sinhgad College of Pharmacy, Vadgaon (Bk.), Pune-411 041, India.

出版信息

Indian J Pharm Sci. 2012 Nov;74(6):512-20. doi: 10.4103/0250-474X.110578.

DOI:10.4103/0250-474X.110578
PMID:23798776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3687920/
Abstract

Floating microspheres have emerged as a potential candidate for gastroretentive drug delivery system. For developing a desired intragastric floatation system employing these microspheres, it is necessary to select an appropriate balance between buoyancy and drug releasing rate. These properties mainly depend on the polymers used in the formulation of the microspheres. Hence it is necessory to study the effect of these polymer concentrations on the various physicochemical properties of the microspheres. Floating microspheres were prepared by emulsion solvent evaporation technique utilising different polymers such as ethyl cellulose, Eudragit(®) RS and Eudragit(®) RL by dissolving them in a mixture of dichloromethane and methanol. Release modifiers studied were hydroxypropyl methylcellulose K4M, hydroxypropyl methylcellulose E50 LV and Eudragit(®) EPO. Prepared microspheres were analysed for particle size, surface morphology, entrapment efficiency, buoyancy, differential scanning calorimetry and in-vitro drug release. Ethyl cellulose and Eudragit(®) EPO resulted microspheres with high percentage yield, excellent spherical shape but had very less buoyancies with a high cumulative drug release. Ethyl cellulose microspheres prepared using hydroxypropyl methylcellulose K4M showed more sustained drug release and high buoyancies than that of the microspheres formulated with the hydroxypropyl methylcellulose E50 LV. Amongst these hydroxypropyl methylcellulose E50 LV showed good balance between buoyancy and the drug release.

摘要

漂浮微球已成为胃滞留药物递送系统的一个潜在候选者。为了利用这些微球开发出理想的胃内漂浮系统,有必要在浮力和药物释放速率之间选择一个合适的平衡点。这些特性主要取决于微球制剂中使用的聚合物。因此,有必要研究这些聚合物浓度对微球各种物理化学性质的影响。通过乳液溶剂蒸发技术,将不同的聚合物如乙基纤维素、Eudragit® RS和Eudragit® RL溶解在二氯甲烷和甲醇的混合物中,制备了漂浮微球。所研究的释放调节剂有羟丙基甲基纤维素K4M、羟丙基甲基纤维素E50 LV和Eudragit® EPO。对制备的微球进行了粒径、表面形态、包封率、浮力、差示扫描量热法和体外药物释放分析。乙基纤维素和Eudragit® EPO制备的微球产率高、球形良好,但浮力很小且药物累积释放率高。使用羟丙基甲基纤维素K4M制备的乙基纤维素微球比用羟丙基甲基纤维素E50 LV制备的微球表现出更持久的药物释放和更高的浮力。在这些微球中,羟丙基甲基纤维素E50 LV在浮力和药物释放之间表现出良好的平衡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe7/3687920/679f6d781e96/IJPhS-74-512-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe7/3687920/3059158f1d33/IJPhS-74-512-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe7/3687920/30c64001e215/IJPhS-74-512-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe7/3687920/ad657647024f/IJPhS-74-512-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe7/3687920/679f6d781e96/IJPhS-74-512-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe7/3687920/3059158f1d33/IJPhS-74-512-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe7/3687920/30c64001e215/IJPhS-74-512-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe7/3687920/ad657647024f/IJPhS-74-512-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fe7/3687920/679f6d781e96/IJPhS-74-512-g007.jpg

相似文献

1
Effect of various polymers concentrations on physicochemical properties of floating microspheres.不同聚合物浓度对漂浮微球物理化学性质的影响。
Indian J Pharm Sci. 2012 Nov;74(6):512-20. doi: 10.4103/0250-474X.110578.
2
Ranitidine Hydrochloride-loaded Ethyl Cellulose and Eudragit RS 100 Buoyant Microspheres: Effect of pH Modifiers.载盐酸雷尼替丁的乙基纤维素和聚丙烯酸树脂RS 100漂浮微球:pH调节剂的影响
Indian J Pharm Sci. 2011 Nov;73(6):626-33. doi: 10.4103/0250-474X.100236.
3
Guar Gum-Based Floating Microspheres of Repaglinide Using 3 Factorial Design: Fabrication, Optimization, Characterization, and Buoyancy Behavior in Albino Rats.基于瓜尔胶的瑞格列奈漂浮微球:采用三因素设计法的制备、优化、表征及在白化大鼠体内的漂浮行为
Assay Drug Dev Technol. 2021 Feb-Mar;19(2):63-74. doi: 10.1089/adt.2020.1006. Epub 2020 Oct 22.
4
Development of theophylline floating microballoons using cellulose acetate butyrate and/or Eudragit RL 100 polymers with different permeability characteristics.使用具有不同渗透特性的醋酸丁酸纤维素和/或尤特奇RL 100聚合物制备茶碱漂浮微球。
Res Pharm Sci. 2010 Jan;5(1):29-39.
5
In vitro Evaluation of Novel Sustained Release Microspheres of Glipizide Prepared by the Emulsion Solvent Diffusion-Evaporation Method.采用乳液溶剂扩散-蒸发法制备的新型格列吡嗪缓释微球的体外评价
J Young Pharm. 2010 Jan;2(1):35-41. doi: 10.4103/0975-1483.62210.
6
Formulation development and in vitro evaluation of gastroretentive hollow microspheres of famotidine.法莫替丁胃滞留中空微球的制剂开发与体外评价
Int J Pharm Investig. 2011 Apr;1(2):105-11. doi: 10.4103/2230-973X.82423.
7
Ethyl cellulose and hydroxypropyl methyl cellulose buoyant microspheres of metoprolol succinate: Influence of pH modifiers.琥珀酸美托洛尔的乙基纤维素和羟丙基甲基纤维素漂浮微球:pH调节剂的影响。
Int J Pharm Investig. 2013 Jul;3(3):163-70. doi: 10.4103/2230-973X.119235.
8
Formulation and development of gastroretentive drug delivery system for ofloxacin.氧氟沙星胃滞留型给药系统的制剂与研发。
Methods Find Exp Clin Pharmacol. 2006 Sep;28(7):433-9. doi: 10.1358/mf.2006.28.7.1003574.
9
Development and evaluation of a gastroretentive drug delivery system for the low-absorption-window drug celecoxib.用于低吸收窗药物塞来昔布的胃滞留型药物递送系统的研发与评价
PDA J Pharm Sci Technol. 2007 Mar-Apr;61(2):88-96.
10
Preparation and in vitro evaluation of propylthiouracil microspheres made of Eudragit RL 100 and cellulose acetate butyrate polymers using the emulsion-solvent evaporation method.采用乳化溶剂蒸发法制备由Eudragit RL 100和醋酸丁酸纤维素聚合物制成的丙硫氧嘧啶微球并进行体外评价。
J Microencapsul. 2005 May;22(3):281-9. doi: 10.1080/02652040500100907.

引用本文的文献

1
Effect of surfactants and polymer composition on the characteristics of polyhydroxyalkanoate nanoparticles.表面活性剂和聚合物组成对聚羟基脂肪酸酯纳米颗粒特性的影响。
ADMET DMPK. 2025 Jun 4;13(3):2723. doi: 10.5599/admet.2723. eCollection 2025.
2
Fabrication of glipizide loaded polymeric microparticles; in-vitro and in-vivo evaluation.格列吡嗪负载型聚合物微粒的制备;体外和体内评价
PLoS One. 2025 Jan 9;20(1):e0313523. doi: 10.1371/journal.pone.0313523. eCollection 2025.
3
Obliteration of infection through the development of a novel thyme oil laden nanoporous gastric floating microsponge.

本文引用的文献

1
Preparation and evaluation of sustained release microballoons of propranolol.制备及评价普萘洛尔缓释微球。
Daru. 2011;19(3):193-201.
2
Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: physicochemical and magnetic properties, in vitro and in vivo drug release.用于关节内给药的含地塞米松的可生物降解超顺磁微球:理化性质和磁性能、体外和体内药物释放。
Eur J Pharm Biopharm. 2009 Aug;72(3):529-38. doi: 10.1016/j.ejpb.2009.03.003. Epub 2009 Mar 20.
3
Preparation of floating microspheres for fish farming.
通过开发一种新型载百里香油的纳米多孔胃漂浮微球来消除感染。
Heliyon. 2024 Apr 8;10(8):e29246. doi: 10.1016/j.heliyon.2024.e29246. eCollection 2024 Apr 30.
4
Formulation optimization and characterization of transdermal film of curcumin by response surface methodology.采用响应面法对姜黄素透皮贴剂进行处方优化及表征
Chin Herb Med. 2020 Dec 5;13(2):274-285. doi: 10.1016/j.chmed.2020.12.001. eCollection 2021 Apr.
5
Preparation and In Vitro-In Vivo Evaluation of Luteolin Loaded Gastroretentive Microsponge for the Eradication of Infections.用于根除感染的木犀草素载药胃滞留微球的制备及体内外评价
Pharmaceutics. 2021 Dec 6;13(12):2094. doi: 10.3390/pharmaceutics13122094.
6
Floating Microspheres of Enalapril Maleate as a Developed Controlled Release Dosage Form: Investigation of the Effect of an Ionotropic Gelation Technique.马来酸依那普利漂浮微球作为一种新型控释剂型:离子凝胶技术效果的研究
Turk J Pharm Sci. 2020 Apr;17(2):159-171. doi: 10.4274/tjps.galenos.2018.15046. Epub 2020 Apr 24.
7
Improved Stability of Rifampicin in the Presence of Gastric-Resistant Isoniazid Microspheres in Acidic Media.在酸性介质中,耐胃酸异烟肼微球存在下利福平稳定性的提高
Pharmaceutics. 2020 Mar 5;12(3):234. doi: 10.3390/pharmaceutics12030234.
8
Probing the effect of various lipids and polymer blends on clopidogrel encapsulated floating microcarriers.研究各种脂质和聚合物共混物对氯吡格雷包封漂浮微载体的影响。
Daru. 2019 Dec;27(2):571-582. doi: 10.1007/s40199-019-00285-0. Epub 2019 Jun 21.
用于养鱼的漂浮微球的制备。
Int J Pharm. 2007 Aug 16;341(1-2):85-90. doi: 10.1016/j.ijpharm.2007.03.049. Epub 2007 Apr 5.
4
Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation.西咪替丁漂浮微球:制剂、表征及体外评价
Acta Pharm. 2005 Sep;55(3):277-85.
5
In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans.含核黄素微球用于健康人体漂浮控释给药系统的体外和体内评价
Int J Pharm. 2004 May 4;275(1-2):97-107. doi: 10.1016/j.ijpharm.2004.01.036.
6
In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method.乳液溶剂扩散法制备的中空微球(微球囊)的漂浮及释药行为的体外评价
Eur J Pharm Biopharm. 2004 Mar;57(2):235-43. doi: 10.1016/S0939-6411(03)00185-1.
7
The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres.药物/聚合物比例对载盐酸维拉帕米微球性质的影响。
Int J Pharm. 2003 Feb 18;252(1-2):99-109. doi: 10.1016/s0378-5173(02)00630-0.
8
Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention.漂浮药物递送系统:一种通过胃滞留实现口服控释给药的方法。
J Control Release. 2000 Feb 3;63(3):235-59. doi: 10.1016/s0168-3659(99)00204-7.
9
Development of oral drug delivery system using floating microspheres.使用漂浮微球的口服给药系统的研发。
J Microencapsul. 1999 Nov-Dec;16(6):715-29. doi: 10.1080/026520499288663.
10
Hollow microspheres for use as a floating controlled drug delivery system in the stomach.用作胃部漂浮控释给药系统的中空微球。
J Pharm Sci. 1992 Feb;81(2):135-40. doi: 10.1002/jps.2600810207.